Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 Monoclonal Antibody With or Without mFOLFOX6 Neoadjuvant Therapy in sMPCC
NCT06002789Phase 2Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- May 2022
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of PD-1 Monoclonal Antibody in colorectal cancer (CRC), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started May 2022; status: recruiting.
02
Drugs
PD-1 Monoclonal Antibody
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06002789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06002789.